The Effects of Age, Endometriosis, Polycystic Ovarium Syndrome, and Obesity on the Success of Embryo Transfer on In Vitro Fertilization

Atthahira Amalia Hafiizha, Uki Retno Budihastuti, Bhisma Murti


Background: One of the important stages in in vitro fertilization (IVF) success is the embryo transfer (ET). Many studies are examining the effect of maternal factors on in vitro fertiliza­tion outcomes. However, studies that are only up to the ET stage are still rare. This study aimed to prove whether maternal factors, espe­cially age, endometriosis, PCOS, and obesity, affect ET success in IVF.

Subjects and Method: This was an analytic observational study with a case-control design. A sample of 111 patients who undergo IVF at Sekar Fertility Clinic, Dr. Moewardi Surakarta, was selected by total sampling. The dependent variable was the ET success. The independent variables were maternal age, history of endo­metriosis, PCOS, and obesity. The data were analyzed by a multiple logistic regression.

Results: The prevalence of ET success in IVF from January 2014 to  November 2019 at Sekar Fertility Clinic, Dr. Moewardi, was 65.77% (73 of 111 cycles). Only a history of endometriosis could affect the ET success which was statis­tically significant (aOR= 0.25; 95% CI= 0.08 to 0.78; p= 0.017). ET success was affected by age, PCOS, and obesity, but it was not statistically significant.

Conclusion: Endometriosis affects the ET success in IVF, and it is statistically significant. While age, PCOS, and obesity affect the ET success in IVF, but they are not statistically significant.

Keywords: embryo transfer, in vitro fertilization, endometriosis, polycystic ovarium syndrome

Correspondence: Atthahira Amalia Hafiizha. Faculty of Medicine, Universitas Sebelas Maret.  Jl.  Ir.  Sutami  36A,  Surakarta  57126,  Central Java.  Email: attha­

Journal of Maternal and Child Health (2020), 05(05): 482-489


Full Text:



Dokras A, Baredziak L, Blaine J, Syrop C, VanVoorhis BJ, Sparks A (2006). Obstetric outcomes after in vitro fertilization in obese and morbidly obese women. Obstet Gynecol. 108(1): 61–69. doi: 10.1097/01.AOG.000-0219768.08249.b6.

González-Comadran M, Schwarz JE, ZegersHochschild F, Souza MDCB, Carreras R, Checa MA (2017). The impact of endometriosis on the outcome of Assisted Reproductive Technology. Reprod Biol Endocrinol. 15(8): 1–7. doi: 10.1186/s12958-016-0217-2.

Hourvitz A, Machtinger R, Maman E, Baum M, Dor J, Levron J (2009). Assisted reproduction in women over 40 years of age: How old is too old? Reprod Biomed Online. 19(4): 599–603. doi: 10.1016/j.rbmo.2009.04.002.

Ji J, Liu Y, Tong XH, Luo L, Ma J, Chen Z (2013). The optimum number of oocytes in IVF treatment: an analysis of 2455 cycles in China. Hum Reprod. 28(10): 2728–2734. doi:10.1093/humrep/det303.

Kodama H, Fukuda J, Karube H, Matsui T, Shimizu Y (1995). High incidence of embryo transfer cancellations in patients with polycystic ovarian syn-drome. Hum Reprod. 10(8): 1962–1967.

Langdon F, Pontre J, Hart RJ (2017). Darwish A. Fertility treatment for women with PCOS. Testes and Ovaries: Func-tional and clinical differences and similarities. IntechOpen. doi: 10.5772/intechopen.71188.

Niederberger C, Pellicer A, Cohen J, Gardner DK, Palermo GD, O'Neill CL, Chow S, et al. (2018). Forty Years of IVF. Fertil Steril. 110(2): 185–324. doi: 10.1097/01.JU.0000553048.134-30.38.

Ozekinci M, Seven A, Olgan S, Sakinci M, Keskin U, Akar ME, Ceyhan ST, et al. (2015). Does obesity have detrimental effects on IVF treatment outcomes? BMC Womens Health. 15(61): 1–7. doi: 10.1186/s12905-015-0223-0.

PERFITRI (2017). IVF Registry. Retrieved from

Prawirohardjo S (2014). Ilmu Kandungan. Edisi ketiga. Jakarta: PT Bina Pustaka Sarwono Prawirohardjo.

Sathya A, Balasubramanyam S, Gupta S, Verma T (2010). Effect of body mass index on in vitro fertilization out-comes in women. J Hum Reprod Sci. 3(3): 135–138. doi: 10.4103/0974-1208.74155.

Singh N, Lata K, Naha M, Malhotra N, Tiwari A, Vanamail P (2014). Effect of endometriosis on implantation rates compared to tubal factor in fresh non donor in vitro fertilization cycles. J Hum Reprod Sci. 7(2): 143– 147. doi: 10.4103/0974-1208.138874.

Sirmans SM, Pate KA (2014). Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 6(1): 1–13. doi: 10.2147/clep.s37559.

Stadtmauer LA, Toma SK, Riehl RM, Talbert LM (2001). Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin like growth factors. Fertil Steril.

(3): 505–509. doi: 10.1016/S0015-0282(00)01766-0.

Tan TY, Lau MSK, Loh SF, Tan HH (2014). Female ageing and reproductive outcome in assisted reproduction cycles. Singapore Med J. 55(6): 305–309. doi: 10.11622/smedj.2014081.

Wolf WM, Wattick RA, Kinkade ON, Olfert MD (2018). Geographical prevalence of polycystic ovary syndrome as determined by region and race/ethnicity. Int J Environ Res Public Health. 15(11): 1–13. doi: 10.3390/ijerph151-12589.

Zegers-Hochschild F, Adamson GD, de Mouzon J, Ishihara O, Mansour R, Nygren K, Sullivan E, et al. (2009). International committee for monitoring assisted reproductive technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009. Fertil Steril. 24(11): 2683-2687. doi: 10.1016/j.fertnstert.2009.09.009.

Zhong YP, Ying Y, Wu HT, Zhou CQ, Xu YW, Wang Q, Li J, et al. (2012). Comparison of endocrine profile and in vitro fertilization outcome in patients with PCOS, ovulatory PCO, or normal ovaries. Int J Endocrinol. 2012: 1–6. doi: 10.1155/2012/492803.


  • There are currently no refbacks.